Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Memantine improves cognition in vascular dementia patients

April 12, 2000

Atlantic submits IND for CT-3 to FDA; phase I trials to commence in France

April 12, 2000

Rasagiline successfully completes phase III trial in PD

April 11, 2000

Pfizer describes SAR in a series of quinazolinone AMPA antagonists at ACS meeting

April 11, 2000

Preclinical study suggests potential for Axonyx compounds in AD

April 11, 2000

Positive results reported for Reminyl in AD therapy

April 11, 2000

Cogent Neuroscience secures funds to accelerate neuroprotective gene discovery program

April 10, 2000

Janssen to discontinue development of R-121919 and substitute with a backup compound

April 10, 2000

NeoTherapeutics completes enrollment in phase IIb Neotrofin trial and initiates open-label extension

April 10, 2000

Intranasal morphine pilot clinical trial results reported

April 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...